Compounded peptides are being promoted and sold by wellness companies without adequate clinical evidence supporting their safety or efficacy. This presents an alarming safety concern, which ECRI and ISMP warned patients, The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Therapeutic Peptides in Aesthetic, Metabolic and Endocrine Conditions: Effects, Safety, Clinical Applications, and Future Perspectives Growth Peptides for Bodybuilding: Expert Insights & Protocols R2 Medical Clinic